Executive management strengthened:Philippe Lavielle appointed Chairman and CEO | Bourse Reflex
Accueil > Actualités > Communiqués

Fermentalg (FALG) FR0011271600

€ 6.17  -0.8%
AJOUTER À : Mon Portefeuille | Ma Liste | Mes alertes

Executive management strengthened:Philippe Lavielle appointed Chairman and CEO

Vendredi 25 Nov 2016 à 18:00

Libourne 24 November 2016 – The Board of Directors of Fermentalg, an industrial biotechnology company specialized in the production of oils and proteins derived from microalgae, has elected to merge the functions of Chairman and Chief Executive Officer. Current Chairman of the Board of Directors, Philippe Lavielle, is now also appointed CEO.

Philippe Lavielle said: "I am delighted to be taking up the operational helm of Fermentalg. My goal is to ensure that the business strategy approved by the Board of Directors is successfully implemented by bringing together and working alongside a strong team that is able to draw on the best new talent."

About Philippe Lavielle

56 years of age and married with three children, Philippe Lavielle holds a Masters from HEC in Paris and a diploma from the International Institute for Management Development (IMD).

An expert in the management of innovative businesses, primarily within the biotech sector, he notably spent more than 20 years with Genencor, one of the leading producers of industrial enzymes and now part of DuPont. At Genencor he worked as Vice President and BU Manager before being named Executive Vice President in charge of Business Development.

Following this, in 2011 Philippe Lavielle was appointed President and CEO of VIRDIA, a company specializing in the development of innovative industrial solutions in the production of biofuels and bioproducts, before moving on to various directorships for California-based start-ups from July 2014. Philippe Lavielle has been a director at Fermentalg since May 2016 and Chairman of the Board since September 2016.

About Fermentalg

Based in Libourne (Gironde), Fermentalg is an industrial biotechnology company and a global leader in the production of oils and proteins derived from the fermentation of microalgae. Its primary markets are the human nutrition and animal feed sectors and the green chemistry industry. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, visit the Fermentalg website at: www.fermentalg.com.

Press Relations:
Investor Relations:
ACTUS finance & communication
Alexandra Prisa
Tel: +33 (0)1 53 67 36 90
ACTUS finance & communication
Jérôme Fabreguettes-Leib
Tel: +33 (0)1 53 67 36 78

Partager sur Facebook
Article Précédent :
Information sur la publication des...
Article Suivant :
Cap des 1 000 chirurgies UNiD franchi

Ecrire un commentaire

J'accepte la charte et que mon commentaire soit publié sur BourseReflex.com 

Les autres actualités

Retour vers 'Communiqués' »

Mots-clés : Strengthened   Libourne   Oils   Microalgae   Since  
Sociétés citées dans cette news : Biotech   TEAM   Fermentalg   Euronext  

Si vous passez un ordre de bourse sur le CAC40 le vendredi soir à 18h, quand sera t-il éxécuté?